1)Ramussen PE, Nielsen FR:Hydronephrosis during pregnancy;A literature survey. Eur J Obstet Gynecol Reprod Biol 27:249-259, 1988
2)Semins MJ, Matlaga BR:Management of urolithiasis in pregnancy. Int J Womens Health 5:599-604, 2013
3)Rosenberg E, et al:Nephrolithiasis during pregnancy;Characteristics, complications, and pregnancy outcome. World J Urol 29:743-747, 2011
4)Semins MJ, Matlaga BR:Management of stone disease in pregnancy. Curr Opin Urol 20:174-177, 2010
5)日本泌尿器科学会,他(編):尿路結石症診療ガイドライン2013年版(第2版),金原出版,2013
6)Drescher M, et al:Antepartm nephrolithiasis and the risk of preterm delivery. Urolithiasis, 2018(epub ahead of print)
7)Bailey G, et al:Perinatal outcomes with tamsulosin therapy for symptomatic urolithiasis. J Urol 195:99-103, 2016
8)Wacker JR, et al:Antihypertensive therapy in patients with pre-eclampsia;A prospective randomized multicentre study comparing dihydralazine with urapidil. Eur J Obstet Gynecol Reprod Biol 127:160-165, 2006
9)Magee LA, et al:The safety of calcium channel blockers in human pregnancy;A prospective, multicenter cohort study. Am J Obstet Gynecol 174:823-828, 1996
10)Thomas WH, Hilary ER:Medications & Mothers' Milk(17th ed), p 858, Springer Publishing Company, 2017
11)Simsek M, et al:The teratogenicity of allopurinol;A comprehensive review of animal and human studies. Reprod Toxicol 81:180-187, 2018
12)LactMed:allopurinol. https://toxnet.nlm.nih.gov/(2019年4月閲覧)